: iStockAnalyst.com Symbols Feed

Value Investing's Comeuppance

Fri, 15 May 2009 23:10:18 GMT

The past eighteen months were difficult for many investors and fund managers across a variety of strategies. The credit crisis resulted in major market stress that yielded correlations of nearly one across equities such that performance was largely dictated by the net long exposure of investors. Nearly halfway through 2009, investors seem willing to view 2008 as a “six sigma” year and probably have little interest in attempting to learn much from it. While in many cases, all investors can do is throw their hands up in exasperation, the past 18 months have provided some interesting lessons to those in value investing circles. Continue reading "Value Investing's Comeuppance"[More...]

2008 Q2 Portfolio Holdings: Bruce Berkowitz, Bob Rodriguez & Mohnish Pabrai

Wed, 20 Aug 2008 14:03:00 GMT

In their 13F-HR filing for Q2 2008, Bruce Berkowitz and his cohorts at the Fairholme Fund continue their shift from energy into healthcare: Fairholme opened huge (relative) positions in Pfizer (PFE), Forest Labs (FRX) and UnitedHealth Group (UNH). The UNH position echos Seth Klarman’s endorsement. I don’t follow the pharma industry too closely but (...)[More...]

NASDAQ Technical Picture - Testing Trendline

Tue, 27 May 2008 16:10:21 GMT